Walther Martin, Gebhardt Peter, Grosse-Gehling Philipp, Würbach Lydia, Irmler Ingo, Preusche Stephan, Khalid Muhammad, Opfermann Thomas, Kamradt Thomas, Steinbach Jörg, Saluz Hans-Peter
Institute of Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, Germany.
Appl Radiat Isot. 2011 Jun;69(6):852-7. doi: 10.1016/j.apradiso.2011.02.040. Epub 2011 Mar 2.
We examined the production, separation, and characterization of (89)Zr, including supplementation of a commercial Cyclone(®) 18/9 with a self-made Solid Target System (STS). Obtained [(89)Zr]Zr-oxalate was used for the labeling of anti-B cell antibodies with desferrioxamine-p-SCN as a bifunctional chelator. (89)Zr-labeled antibodies were injected in DBA/1 mice to examine usability for detection of B cells in vivo. PET measurements showed binding of (89)Zr-labeled anti-B cell antibodies in tissues with high frequencies of B cells, i.e. in spleen and lymph nodes.